EE200800070A - HDAC inhibiitorite kasutamine lmfoomide raviks - Google Patents

HDAC inhibiitorite kasutamine lmfoomide raviks

Info

Publication number
EE200800070A
EE200800070A EEP200800070A EEP200800070A EE200800070A EE 200800070 A EE200800070 A EE 200800070A EE P200800070 A EEP200800070 A EE P200800070A EE P200800070 A EEP200800070 A EE P200800070A EE 200800070 A EE200800070 A EE 200800070A
Authority
EE
Estonia
Prior art keywords
lymphomas
treatment
hdac inhibitors
hdac
inhibitors
Prior art date
Application number
EEP200800070A
Other languages
English (en)
Inventor
Wisdom Atadja Peter
Shao Wenlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of EE200800070A publication Critical patent/EE200800070A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200800070A 2006-06-28 2007-06-26 HDAC inhibiitorite kasutamine lmfoomide raviks EE200800070A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80602606P 2006-06-28 2006-06-28
PCT/US2007/014985 WO2008002634A1 (en) 2006-06-28 2007-06-26 Use of hdac inhibitors for the treatment of lymphomas

Publications (1)

Publication Number Publication Date
EE200800070A true EE200800070A (et) 2009-02-16

Family

ID=38617341

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200800070A EE200800070A (et) 2006-06-28 2007-06-26 HDAC inhibiitorite kasutamine lmfoomide raviks

Country Status (6)

Country Link
US (2) US20090281159A1 (et)
CA (1) CA2654936A1 (et)
EE (1) EE200800070A (et)
MX (1) MX2008016503A (et)
TR (1) TR200809829T1 (et)
WO (1) WO2008002634A1 (et)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001285042A1 (en) * 2000-08-18 2002-03-04 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
CN100457183C (zh) * 2001-11-06 2009-02-04 诺瓦提斯公司 环氧酶-2抑制剂/组蛋白脱乙酰酶抑制剂的组合

Also Published As

Publication number Publication date
WO2008002634A1 (en) 2008-01-03
US20110124701A1 (en) 2011-05-26
CA2654936A1 (en) 2008-01-03
TR200809829T1 (tr) 2009-06-22
MX2008016503A (es) 2009-06-08
US20090281159A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
BRPI0719204A2 (pt) Inibidores de hdac
CY2017016I2 (el) Αναστολεις πρωτεασωματος
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
CR10831A (es) INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
CY2014011I1 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
LTC1912640I2 (lt) HDAC inhibitoriaus panobinostato panaudojimas mielomos gydymui
NO345061B1 (no) Anvendelse av DPP-IV inhibitorer
DE602007011342D1 (de) Endoskop-Behandlungswerkzeug
BRPI0817860A2 (pt) inibidores de histona deacetilase
DK2383271T3 (da) Aminoquinoloner som GSK-3-inhibitorer
FI20065757A (fi) Beta-laktamaasin käyttö
DE602007014130D1 (de) Ultraschallendoskop
ATE495153T1 (de) Arylsulfonylpyrrolidine als 5-ht6-inhibitoren
BRPI0821247A2 (pt) Inibidores de histona deacetilase
LTPA2016019I1 (lt) Išsėtinės sklerozės (MS) gydymas kampatu-1H
GB0624187D0 (en) HDAC inhibitors
IL210489A0 (en) Use of hdac inhibitors for the treatment of hodgkin's disease
EP2015741A4 (en) HISTONE DESACETYLASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATION
DK1991718T3 (da) Korrosionsinhibitorer
IL201466A0 (en) Use of hdac inhibitors for the treatment of bone destruction
EE200800070A (et) HDAC inhibiitorite kasutamine lmfoomide raviks
FI20075320A0 (fi) Uusia käyttökelpoisia inhibiittoreita